Bicycle Therapeutics PLC
BCYC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761612
No open-market purchases or sales by Bicycle Therapeutics PLC insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Bicycle Therapeutics PLC changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 79 | 1 | 87 | +9 |
| Shares | 23.1M | 907.0K | 23.5M | +1.29M (+5.8%) |
| Value | $538.0M | $21.1M | $695.9M | +$179.0M (+34.6%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Bicycle Therapeutics PLC at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 2,264,801 | $67.0M | 80.44% |
| Polar Capital Holdings Plc | 750,000 | $22.2M | 0.18% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 300,968 | $8.91M | 0.03% |
| Soleus Capital Management, L.P. | 258,400 | $7.65M | 1.10% |
| Group One Trading, L.P. | 38,784 | $1.15M | 0.04% |
| Susquehanna International Group, LLP | 37,055 | $1.10M | 0.00% |
| Vident Investment Advisory, LLC | 23,957 | $709.1K | 0.03% |
| Cubist Systematic Strategies, LLC | 13,190 | $390.4K | 0.00% |
| Fishman Jay A Ltd | 10,500 | $310.8K | 0.04% |
| Jump Financial, LLC | 7,400 | $219.0K | 0.01% |
| Twelve Points Wealth Management LLC | 7,200 | $213.1K | 0.15% |
| Natixis | 3,613 | $106.9K | 0.00% |
| HealthInvest Partners AB | 226 | $6.69K | 0.01% |
| BNP Paribas Arbitrage, SA | 162 | $4.79K | 0.00% |
| Advisory Services Network, LLC | 115 | $3.40K | 0.00% |
| TCI Wealth Advisors, Inc. | 73 | $2.16K | 0.00% |
| Ronald Blue Trust, Inc. | 20 | $0 | 0.00% |
Sold out (8)
Institutions that held Bicycle Therapeutics PLC at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| UBS Oconnor LLC | 67,625 | $1.57M |
| Voloridge Investment Management, LLC | 62,667 | $1.46M |
| Two Sigma Investments, LP | 49,500 | $1.15M |
| Ensign Peak Advisors, Inc | 24,033 | $559.0K |
| Octagon Capital Advisors LP | 20,000 | $465.0K |
| Alps Advisors Inc | 16,186 | $376.0K |
| Almanack Investment Partners, LLC. | 524 | $12.0K |
| Meeder Asset Management Inc | 2 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Bicycle Therapeutics PLC at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| SV Health Investors, LLC | 907,032 | $21.1M |